Diarrhea News and Research

Latest Diarrhea News and Research

Risks from colorectal cancer

Although the presenting features of colorectal cancer are well known, the risks they confer are less well defined.

16 Apr 2009

South Australian hospital battles to contain superbug VRE

The cancer ward at the Royal Adelaide Hospital (RAH) in South Australia is currently battling to cope with an antibiotic-resistant bacteria called Vanocomycin-resistant Enterococci (VRE), a form of bacteria which lives in the gut.

16 Apr 2009

Vaccine for Coeliac disease could mean the end of gluten free diets

Australian scientists have developed an experimental vaccine to treat coeliac disease. The team at the Walter and Eliza Hall (WEHI) Institute in Melbourne are hoping a phase 1 clinical trial of the vaccine, due to begin this month, will eventually lead to an effective clinical treatment for the disease.

15 Apr 2009

Oral rehydration solution for diarrhea

Newer polymer-based formulations of oral rehydration solution given to treat diarrhoea may offer some benefits over older sugar-salt formulations.

14 Apr 2009

Vaccine for Enterotoxigenic E. coli developed

A Michigan State University researcher has developed a working vaccine for a strain of E. coli that kills 2 million to 3 million children each year in the developing world.

14 Apr 2009

New easy to understand guide on treatments for osteoarthritis of the knee

A new pair of plain-language guides from the Agency for Healthcare Research and Quality (AHRQ) examines the effectiveness, safety, and adverse effects of various treatments for osteoarthritis of the knee, including glucosamine and chondroitin, fluid injections, arthroscopic surgery, pain medications and other approaches.

13 Apr 2009

Gene targeting discovery opens door for vaccines and drugs

In a genetic leap that could help fast track vaccine and drug development to prevent or tame serious global diseases, DMS researchers have discovered how to destroy a key DNA pathway in a wily and widespread human parasite.

13 Apr 2009

Diarrhoea treatment fails to reach the poorest children

Acute dehydration caused by diarrhoea is one of the most common causes of death amongst children in low and middle-income countries. A new study from the Swedish medical university Karolinska Institutet now shows that almost half a billion cases of child diarrhoea a year could be treated if they all received treatment equal to the best standards in their home countries.

7 Apr 2009

FDA warns consumers to avoid eating Strubs Norwegian style steelhead salmon

The U.S. Food and Drug Administration today warned consumers not to eat Strubs Norwegian Style Sliced Smoked Steelhead Salmon in 300 gram packages because of potential contamination with the bacterium Listeria monocytogenes. L. monocytogenes is a foodborne pathogen that can cause serious illness and death.

7 Apr 2009

Complementary and alternative medicines can be safe, effective for kids

Today, more children than ever are being treated with complementary and alternative therapies.

6 Apr 2009

Researchers find an increased rate of unintentional injection of epinephrine from auto-injectors for anaphylaxis

Researchers find an increased rate of unintentional injection of epinephrine from auto-injectors for anaphylaxis (severe allergic reactions) and urge people who may need to administer the life-saving drug to themselves or others in an allergic emergency to receive regular coaching in its proper use.

6 Apr 2009

GE Healthcare collaborates with CDC on electronic medical records

GE Healthcare has announced a collaboration with the Centers for Disease Control and Prevention's (CDC) National Center for Public Health Informatics.

6 Apr 2009

Targeted approach to kill specific disease-causing bacteria in the mouth

Research to develop a narrow-spectrum antibiotic that can target a particular species of bacteria without harming the other "good" bacteria present was described at the Society for General Microbiology meeting at Harrogate today (Thursday April 2).

1 Apr 2009

Researchers examine norovirus gastroenteritis

A new study from the University of Southampton is examining why norovirus gastroenteritis - popularly referred to as 'gastric flu' - is confined to specific parts of the small intestine.

1 Apr 2009

Doctors identify patients at high risk of Clostridium difficile

Doctors have developed and validated a clinical prediction rule for recurrent Clostridium difficile ( C. difficile ) infection that was simple, reliable and accurate, and can be used to identify high-risk patients most likely to benefit from measures to prevent recurrence.

1 Apr 2009

The use of native African plants in veterinary medicine studied by K-State researchers

When animals in southern Africa are sick, often the first place their caretakers look for help is from native plants.

30 Mar 2009

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

30 Mar 2009

FDA approves Afinitor oral tablets (everolimus) for advanced form of kidney cancer

The U.S. Food and Drug Administration today approved Afinitor oral tablets (everolimus) for the treatment of patients with advanced kidney cancer whose disease has progressed after treatment with other cancer therapies.

30 Mar 2009

Dapagliflozin trial results indicate improvement in key glycemic measures in treatment-naive type 2 diabetes

Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.

29 Mar 2009

Amicus Therapeutics presents positive results from phase 2 extension study of Amigal for Fabry disease

Amicus Therapeutics has announced positive results from its ongoing Phase 2 extension study of its investigational drug, Amigal (migalastat HCL) for Fabry disease.

29 Mar 2009